QT Imaging Holdings, Inc. (QTIWW) stock
Close on Oct 15, 2026Market cap $27.52MP/E –Yield –
QT Imaging Holdings, Inc. grew revenue 157.3% to $29.58M over the twelve months to Sep 30, 2026. Free cash flow was -$14.12M. At the latest close the market valued the company at $27.52M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $27.52M
- P/E ratio
- –
- Price to sales
- 0.93
- Price to book
- 10.39
- Dividend yield
- –
- Free cash flow yield
- -51.31%
Fundamentals
- Revenue
- $29.58M
- Net income
- -$16.16M
- EPS, diluted
- -$1.12
- Free cash flow
- -$14.12M
- Book value per share
- $0.17
- Diluted shares
- 16M
Trading
- Next earnings
- Mar 24, 2027 (estimated, before the open)
- Previous close
- $0.12
- Open
- $0.09
- Day's range
- $0.09 – $0.13
- Volume
- 2,600
- Average volume (20 days)
- 34,728
- Beta (5 years)
- 0.05
- 52-week range
- $1.87 – $7.60
- RSI (14 days)
- 31.1
- Volatility (1 year)
- 64.8%
- Relative volume
- 1.46×
- WACC
- 7.4%
Market cap history
Month-end market cap since 2022, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 15, 2026. The S&P 500 is measured by the SPY fund.
| Period | QTIWW | S&P 500 | Difference | QTIWW per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -7.6% | +2.2% | −9.8 pts | ||
| 3 months | -7.6% | +2.5% | −10.1 pts | ||
| Year to date | +11.9% | +14.1% | −2.1 pts | ||
| 1 year | -55.6% | +17.3% | −72.8 pts |
Five years at a glance
Fiscal years 2021 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases QT Imaging filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Results
- Update
- Results
- Results
- News
About QT Imaging
Electromedical & Electrotherapeutic Apparatus
QT Imaging Holdings, Inc. develops and commercializes non-invasive medical body imaging systems based on low-energy transmitted sound. Its flagship offering is the Breast Acoustic CT scanner, an automated Class II system that provides high-resolution three-dimensional breast imaging without ionizing radiation or breast compression. The company also builds a cloud-based software-as-a-service platform that integrates artificial intelligence tools for quantitative tissue analysis and diagnostic decision support. Its target users and markets include women requiring adjunctive breast screening—particularly those with dense breast tissue or elevated risk—as well as healthcare providers, hospitals, and outpatient radiology centers.
Company profile, executives and historyQT Imaging stock: common questions
What is QT Imaging's stock price?
QTIWW closed at $0.13 on Oct 15, 2026, up 7.75% on the day. Over the past 52 weeks it traded between $1.87 and $7.60.
What is QT Imaging's market cap?
QT Imaging was worth $27.52M at the close on Oct 15, 2026: the share price times the diluted shares outstanding.
What is QTIWW's P/E ratio?
QT Imaging lost money over the twelve months to Sep 30, 2026 (diluted EPS -$1.12), so it has no meaningful P/E ratio.
How much revenue does QT Imaging make?
QT Imaging reported revenue of $29.58M for the twelve months to Sep 30, 2026, up 157.3% from a year earlier.
Does QT Imaging pay a dividend?
No. QT Imaging has not paid a cash dividend over the last twelve months.
When does QT Imaging report earnings next?
QT Imaging is expected to report Q4 FY2026 results on Mar 24, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has QTIWW stock performed over the past year?
Including dividends, QTIWW returned -55.6% over the past year, against +17.3% for the S&P 500.
Who are QT Imaging's competitors?
Companies most similar to QT Imaging by business, industry and size include HYPR, CV, FOCL, PROF, NNOX.
See a number that looks wrong?